Medicamen Biotech Limited (MEDICAMEQ) Financial History

Name: Medicamen Biotech Limited (MEDICAMEQ) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-10-22

Medicamen Biotech Limited (MEDICAMEQ) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in New Delhi, India with about 405 employees. Its market capitalization is roughly ₹4 billion. In the fiscal year ended 2026-03-31, MEDICAMEQ reported ₹2.0B in revenue and ₹96M in net income.

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, and sells pharmaceutical formulations in India and internationally. The company provides tablets, capsules, dry syrups, oral liquids, ointments, and other pharmaceutical dosage forms.

Interactive charts & full statements → Open the MEDICAMEQ valuation workbench →

MEDICAMEQ Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹2.0B	₹2.0B	₹1.6B	₹1.8B	₹1.4B	—
Gross Profit	₹1.0B	₹960M	₹779M	₹698M	₹549M	—
Operating Income (EBIT)	₹121M	₹124M	₹68M	₹174M	₹189M	—
Net Income	₹103M	₹96M	₹71M	₹109M	₹148M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MEDICAMEQ Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	₹479M	₹606M	₹469M	₹472M	₹430M	—
Gross Profit	₹268M	₹284M	₹232M	₹240M	₹203M	—
Operating Income (EBIT)	₹25M	₹37M	₹26M	₹33M	₹28M	—
Net Income	₹21M	₹39M	₹16M	₹27M	₹22M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MEDICAMEQ Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹14M)	(₹13M)	(₹13M)	(₹13M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MEDICAMEQ Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹3.7B	₹3.0B	₹2.9B	₹2.8B	—
Total Liabilities	₹964M	₹841M	₹876M	₹851M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MEDICAMEQ viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

TMAN · T.Man Pharmaceutical Public Company Limited — THB 4 billion
JENBURPH · Jenburkt Pharmaceuticals Limited — ₹4 billion
0719 · Shandong Xinhua Pharmaceutical Company Limited — HK$4 billion
CURA · Curaleaf Holdings, Inc. — C$4 billion
HIK · Hikma Pharmaceuticals PLC — £4 billion
AAREYDRUGS · Aarey Drugs & Pharmaceuticals Limited — ₹3 billion
SFZN · Siegfried Holding AG — CHF 3 billion
AMBALALSA · Ambalal Sarabhai Enterprises Limited — ₹3 billion

← MEDIASSIST All “M” companies MEDICAPQ →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.